Brind.

Company announced trial initiation from San Francisco on August 11, 2025.

2 reports, 2 independent Updated Aug 11

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Company announced trial initiation from San Francisco on August 11, 2025.

Who's involved

What this event is mainly about

BioPharma San Francisco

Keep exploring

The entities involved

BioPharma
company in Jílové u Prahy, Czech Republic
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.Mon 02:47
- BioPharma and Milestone Pharmaceuticals are small-cap healthcare companies.Wed 08:33
San Francisco
consolidated city and county in California, United States
- Lee Jae Myung met with a community in San Francisco and stated his goal to improve voting access in China.Mon 09:38
- Mayor Daniel Lurie and the Board of Supervisors discussed economic impact and public safety improvements in San Francisco.Sun 23:52

Coverage

Newest first; wire copies grouped

Aug 11GlobeNewswireGT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2 The first patient in Cohort 3, the fifth patient in the trial, has completed the first week of cycle
Aug 7Business WireVir Biotechnology Provides Corporate Update and Reports Second Quarter 2025 Financial Results – ECLIPSE registrational program in chronic hepatitis delta fully underway – First patient dosed in Phase